Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label Cisplatin. Show all posts
Showing posts with label Cisplatin. Show all posts
Tuesday, May 29, 2012

paywalled: Long-term survival in patients with clear cell adenocarcinoma of ovary treated with irinotecan hydrochloride plus cisplatin therapy as first-line

›
Long-term survival in patients with clear cell adenocarcinoma of ovary treated with irinotecan hydrochloride plus cisplatin therapy as first...
1 comment:
Tuesday, May 08, 2012

paywalled: Science behind cisplatin-induced nephrotoxicity in humans: A clinical study

›
Science behind cisplatin-induced nephrotoxicity in humans: A clinical study : Publication year: 2012 Objective To investigate the relati...
Wednesday, March 21, 2012

abstract: Regimens with intraperitoneal cisplatin plus intravenuous cyclophosphamide and intraperitoneal carboplatin plus intravenuous cyclophosphamide are equally effective in second line intraperitoneal chemotherapy for advanced ovarian cancer.

›
Regimens with intraperitoneal cisplatin plus intravenuous cyclophosphamide and intraperitoneal carboplatin plus intravenuous cyclophosphamid...
Saturday, March 17, 2012

abstract: Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancer.

›
Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancer. Abstract PURPOSE:...
Thursday, February 16, 2012

abstract: Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide (VPCBAE) in the management of three patients with small-cell carcinoma of the ovary

›
Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide (VPCBAE) in the management of three patients with small-cell...
Thursday, January 26, 2012

BioMed Central Blog : DIM: hope for ovarian cancer (anti-cancer drug Diindolylmethane (DIM))

›
"Importantly, Kandala and Srivastava also showed that DIM enhanced the anti-cancer effects of cisplatin in both human ovarian cancer ...
Tuesday, January 03, 2012

in research: Combinations of Resveratrol, Cisplatin and Oxaliplatin Applied to Human Ovarian Cancer Cells

›
Wednesday, March 30, 2011

EvidenceUpdates - Interventions for preventing neuropathy caused by cisplatin and related compounds

›
BACKGROUND: Cisplatin and several related antineoplastic agents used to treat many types of solid tumors are neurotoxic, and most patients...
Friday, March 04, 2011

Cochrane review: Interventions for preventing neuropathy caused by cisplatin and related compounds

›
AUTHORS' CONCLUSIONS: At present, the data are insufficient to conclude that any of the purported chemoprotective agents (acetylcystei...
Wednesday, February 16, 2011

Randomized Phase III Clinical Trial Evaluating Weekly Cisplatin for Advanced Epithelial Ovarian Cancer — J. Natl. Cancer Inst.

›
Thus, increasing dose intensity of cisplatin does not improve PFS or OS compared with standard chemotherapy.
Friday, January 14, 2011

Randomized Phase III Clinical Trial Evaluating Weekly Cisplatin for Advanced Epithelial Ovarian Cancer

›
"Thus, increasing dose intensity of cisplatin does not improve PFS or OS compared with standard chemotherapy."
Wednesday, November 17, 2010

science article: Duke continues investigation as geneticist's work retracted (ovarian cancer patients to cisplatin drug therapy)

›
Sunday, November 14, 2010

Phase 1/pharmacology study of intraperitoneal topotecan alone and with cisplatin: potential for consolidation in ovarian cancer.

›
Monday, October 11, 2010

Adding topotecan to standard treatment for ovarian cancer does not improve progression-free survival

›
Blogger's Note: discussions/research have been made in the past regarding triple therapies (irrespective of types of therapies) with mo...
Wednesday, August 25, 2010

in research - Abstract: RNAi screening of the kinome identifies modulators of cisplatin response in ovarian cancer cells.

›
CONCLUSIONS: Our data provides kinase targets that could be exploited to design better therapeutics for ovarian cancer patients. We also dem...
Thursday, July 29, 2010

Vascular Endothelial Growth Factor Is a Promising ... [Mol Cancer Ther. 2010] - PubMed result

›
Mol Cancer Ther. 2010 Jul 27. [Epub ahead of print] Vascular Endothelial Growth Factor Is a Promising Therapeutic Target for the Treatm...
Friday, April 30, 2010

Abstract/free access: Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth

›
Note: in research (cisplatin/radiation resistant cell lines)/highly technical "This study demonstrates a novel curcumin pre-treatmen...
Saturday, March 27, 2010

Vitamin E neuroprotection for cisplatin neuropathy: A randomized, placebo-controlled trial -- Neurology

›
Conclusions: This phase III study confirms the neuroprotective role of vitamin E against cisplatin peripheral neurotoxicity. Vitamin E supp...
Monday, February 08, 2010

abstract: Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?

›
Saturday, February 06, 2010

Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer

›
Conclusion: Intraperitoneal chemotherapy regimens using carboplatin or cisplatin and dropping day 8 IP paclitaxel have less toxicity and le...